In–Vitro Anticancer and Antibacterial Activities of Brominated Indeno[1,2-b]qinoline Amines Supported with Molecular Docking and MCDM**
dc.contributor.author | Aydın, Ali | |
dc.contributor.author | Ökten, Salih | |
dc.contributor.author | Erkan, Sultan | |
dc.contributor.author | Bulut, Merve | |
dc.contributor.author | Özcan, Evrencan | |
dc.contributor.author | Tutar, Ahmet | |
dc.contributor.author | Eren, Tamer | |
dc.date.accessioned | 2025-01-21T16:28:00Z | |
dc.date.available | 2025-01-21T16:28:00Z | |
dc.date.issued | 2021 | |
dc.department | Kırıkkale Üniversitesi | |
dc.description.abstract | The present study describes mono substituted indeno[1,2-b]quinolines (3 a–c and 5) have much more antiproliferative potentials than positive controls against A549, HeLa, MCF7 and Hep3B cell lines (IC50 values 1.1–29.6 ?g/mL) and show similar cytotoxicity (14.3 % to 19.8 %) to cells such as controls. Moreover, the mono substituted indeno[1,2-b]quinoline amines (3 a–c and 5) exhibit significant antimicrobial activity with MIC values between 15.62 ?g/mL and 250 ?g/mL. The compounds can also bind to DNA in the groove binding mode with a binding constant range of 1.1×103–1.1×105 M?1. The anticancer and antibacterial properties of compounds were confirmed with the molecular docking simulation for their pharmacokinetic. As a result, the preliminary experimental data and a multi-criteria decision-making methodology (MCDM) indicated that the mono substituted indeno[1,2-b]quinoline amine derivatives, especially 3 a and 5, exhibit effective pharmacological properties. parameters and their interaction with related cells at the molecular level. © 2021 Wiley-VCH GmbH | |
dc.identifier.doi | 10.1002/slct.202004753 | |
dc.identifier.endpage | 3295 | |
dc.identifier.issn | 2365-6549 | |
dc.identifier.issue | 13 | |
dc.identifier.scopus | 2-s2.0-85107543872 | |
dc.identifier.scopusquality | Q3 | |
dc.identifier.startpage | 3286 | |
dc.identifier.uri | https://doi.org/10.1002/slct.202004753 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12587/23443 | |
dc.identifier.volume | 6 | |
dc.indekslendigikaynak | Scopus | |
dc.language.iso | en | |
dc.publisher | John Wiley and Sons Inc | |
dc.relation.ispartof | ChemistrySelect | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.snmz | KA_20241229 | |
dc.subject | Antibacterial agents; Antitumor agents; Biological activity; Indeno[1,2-b]quinoline amine; Molecular docking; Multi criteria decision making | |
dc.title | In–Vitro Anticancer and Antibacterial Activities of Brominated Indeno[1,2-b]qinoline Amines Supported with Molecular Docking and MCDM** | |
dc.type | Article |